| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 06/29/1996 | CA2166246A1 Process of producing .alpha.-l-aspartyldipeptide amide derivatives |
| 06/26/1996 | EP0718627A1 A process for preparing diagnostic reagent for syphilis |
| 06/26/1996 | EP0718402A2 Penicillin V amidohydrolase gene from fusarium oxysporum |
| 06/26/1996 | EP0718401A1 Sucrose phosphate synthase (SPS), its process for preparation, its cDNA, and utilisation of cDNA to modify the expression of SPS in the plant cells |
| 06/26/1996 | EP0718308A2 Peptide derivatives having binding activity to modified low density lipoprotein |
| 06/26/1996 | EP0717749A1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 06/26/1996 | CN1125232A Method for extracting protein by starch slurry deep oscillation and its equi;ment |
| 06/26/1996 | CN1125231A Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 06/25/1996 | US5530103 Method for the purification of PC protein from Borrelia burgdorferi |
| 06/25/1996 | US5530101 Humanized immunoglobulins |
| 06/25/1996 | US5530098 Human B-cell differentiation factor and process of producing said factor |
| 06/25/1996 | US5529792 Homogenizing chicken embryo or adult bovine brain tissue, centrifuging, applying to cation exchanger, separating active fractions by gel filtration chromatography, purifying by reverse phase liquid chromatography |
| 06/25/1996 | US5529756 Apparatus and method for polymer synthesis using arrays |
| 06/25/1996 | CA1338415C C-terminal amidating enzyme composition, process for preparing, and use of the same |
| 06/24/1996 | CA2163159A1 Penicillin v amidohydrolase gene from fusarium oxysporum |
| 06/20/1996 | WO1996018957A1 A method for predicting protein structure |
| 06/20/1996 | WO1996018903A1 Combinatorial libraries having a predetermined frequency of each species of test compound |
| 06/20/1996 | WO1996018734A1 Production of recombinant secretory component |
| 06/20/1996 | WO1996018647A1 Spray dried erythropoietin |
| 06/20/1996 | WO1996018643A1 Tachykinin antagonists |
| 06/20/1996 | WO1996018642A1 Amino acids for making betides and methods of screening and making betide libraries |
| 06/20/1996 | WO1996018641A1 Modulators of the function of fas/apo1 receptors |
| 06/20/1996 | CA2207435A1 Combinatorial libraries having a predetermined frequency of each species of test compound |
| 06/20/1996 | CA2206258A1 Amino acids for making betides and methods of screening and making betide libraries |
| 06/20/1996 | CA2204130A1 Tachykinin antagonists |
| 06/19/1996 | EP0717109A1 Synthetic DNA derived recombinant HIV-2 antigens |
| 06/19/1996 | EP0717048A1 Cyclic hexapeptides and their mixings, process to synthesize them and their use |
| 06/19/1996 | EP0621899B1 Expression signal-peptide-free staphylokinases |
| 06/19/1996 | EP0527778B1 Improved process of purifying recombinant proteins and compounds useful in such process |
| 06/19/1996 | EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor |
| 06/19/1996 | EP0506923B1 A collagen binding protein as well as its preparation |
| 06/18/1996 | US5527901 Tetrasaccharides bonding to a label, a chromatograpic support or protective group for isolating, purifying antibodies |
| 06/18/1996 | US5527881 Procedure for preparing salmon calcitonin |
| 06/18/1996 | US5527681 Immobilized molecular synthesis of systematically substituted compounds |
| 06/13/1996 | WO1996017942A1 Production of peptides using recombinant fusion protein constructs |
| 06/13/1996 | WO1996017941A2 Production of c-terminal amidated peptides from recombinant protein constructs |
| 06/13/1996 | WO1996017929A1 Polypeptide with reduced allergenicity |
| 06/13/1996 | WO1996017631A1 Heat treated blood plasma proteins |
| 06/13/1996 | CA2206852A1 Polypeptide with reduced allergenicity |
| 06/13/1996 | CA2206848A1 Production of peptides using recombinant fusion protein constructs |
| 06/12/1996 | EP0716095A1 Method for quantitative determination of fas antigen |
| 06/12/1996 | EP0414915B1 New superoxide dismutase |
| 06/12/1996 | CN1124491A Inhibitor of stem cell proliferation and uses thereof |
| 06/12/1996 | CN1032019C Process for recombinant biocides using organisms |
| 06/11/1996 | US5526281 Machine-learning approach to modeling biological activity for molecular design and to modeling other characteristics |
| 06/11/1996 | US5525707 N-terminal peptide degradation utilizing dialkylthiocarbamoylhalides |
| 06/11/1996 | US5525590 Immunosuppressants, antiinflammatory and antiparasitic |
| 06/11/1996 | US5525519 Precipitating with a ph adjusted solution of polyoxyethylene glycol and polyvinylpyrrolidone |
| 06/11/1996 | US5525508 Purified antigen derived from homogenizing nematodes, extracting and chromatographing on wheat-germ lectin sepharose column |
| 06/11/1996 | US5525502 DNA encoding chitin deacetylase |
| 06/11/1996 | US5525465 Detection, therapy |
| 06/11/1996 | CA1338381C Minactivin - (plasminogen activator inhibitor-2) |
| 06/09/1996 | CA2164374A1 Method for quantitative determination of fas antigen |
| 06/06/1996 | WO1996016714A1 Method and device for separating fibrin monomer from blood plasma |
| 06/05/1996 | EP0714665A2 Osteogenic devices |
| 06/05/1996 | EP0714512A1 Marking of products to establish identity and source |
| 06/05/1996 | EP0714412A1 Heparin functional affinity supports |
| 06/05/1996 | EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 06/05/1996 | EP0714406A1 Refolding of polypeptides like recombinant insulin-like growth factor igf-i |
| 06/05/1996 | EP0714405A1 Therapeutic and diagnostic agents for amyloidosis |
| 06/05/1996 | EP0714403A1 Aqueous multiple-phase isolation of polypeptide |
| 06/05/1996 | EP0714402A1 Polymer modification |
| 06/05/1996 | EP0669935B1 Compounds useful as sweetening agents and process for their preparation |
| 06/05/1996 | EP0517733B1 Enhanced capillary zone electrophoresis and apparatus for performance thereof |
| 06/05/1996 | CN1031943C Method of purifying protein |
| 06/04/1996 | US5523231 Method to isolate macromolecules using magnetically attractable beads which do not specifically bind the macromolecules |
| 06/04/1996 | US5523215 Culturing host cell expressing desired protein in medium containing copper ions, disrupting, incubating insoluble fraction with chaotropic agent to dissolve contaminants, separating, treating insoluble fraction with reducing agent |
| 06/04/1996 | CA2054551C Monoclonal antibodies to mite allergen and the use thereof |
| 05/30/1996 | WO1996016172A2 Modulators of anchoring protein function |
| 05/30/1996 | WO1996016168A1 Chemical modification of repetitive polymers to enhance water solubility |
| 05/30/1996 | WO1996016078A1 Method of making a library of compounds |
| 05/30/1996 | WO1996016077A3 Reagent for quantifying free amine groups |
| 05/30/1996 | WO1996016077A2 Reagent for quantifying free amine groups |
| 05/30/1996 | WO1996015816A2 Stable n-terminally linked dtpa:protein compositions and methods |
| 05/30/1996 | WO1996015803A1 SELECTIVE ACYLATION OF ε-AMINO GROUPS |
| 05/30/1996 | WO1996015797A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
| 05/30/1996 | CA2205583A1 Method of making a library of compounds |
| 05/30/1996 | CA2205219A1 Chemical modification of repetitive polymers to enhance water solubility |
| 05/30/1996 | CA2205061A1 Selective acylation of .epsilon.-amino groups |
| 05/30/1996 | CA2181826A1 Modulators of anchoring protein function |
| 05/29/1996 | EP0713533A1 Biocatalytic methods for synthesizing and identifying biologically active compounds |
| 05/29/1996 | EP0713530A1 High level expression, purification and refolding of the neisseria meningitidis outer membrane group b porin proteins |
| 05/29/1996 | EP0650364A4 Purification of factor ix. |
| 05/29/1996 | EP0618811A4 Proteolytic mixture containing escharase and method of isolating same. |
| 05/29/1996 | EP0471809B1 Method for preparing n-protected (2s,3s)-3-ethylaspartic acid dialkyl esters |
| 05/29/1996 | EP0431129B1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 05/29/1996 | CN1123550A Process for removing endotoxins |
| 05/29/1996 | CN1123326A Modified gene of human tumor necrotizing factor and its production process |
| 05/29/1996 | CN1031880C Process for preparing novel analogs of peptidase substrates |
| 05/28/1996 | US5521319 Biotinylation reagent and method of use thereof |
| 05/28/1996 | US5521157 Modified polypeptide compound with VIP-like activity |
| 05/28/1996 | US5521155 Antibiotic active against grampositive bacteria |
| 05/28/1996 | US5521154 Imidoester cross-linked hemoglobin compositions |
| 05/28/1996 | US5521097 Method of determining amino acid sequence of protein or peptide from carboxy-terminal |
| 05/28/1996 | US5520885 Fibrinogen processing apparatus, method and container |
| 05/28/1996 | CA1338365C Synthetic antigens of sialic acid and derivatives thereof |
| 05/23/1996 | WO1996015450A1 A partitioned microelectronic device array |
| 05/23/1996 | WO1996015153A1 Human antibodies to t-cell receptor peptides and methods for their preparation |
| 05/23/1996 | WO1996015146A1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 05/23/1996 | WO1996015142A1 Process for performing retro-aldol reaction |